Steve HOLMES
Co-Founder
Cholangio.Org
Co-Founder and CEO,
Cholangiocarcinoma Foundation Australia.
Late-stage IV cholangiocarcinoma survivor.
First documented complete response from a late-stage setting within the landmark KEYNOTE-158 clinical trial.
When asked what I do, my answer is simple:
Cancer biology, specifically the biliary system and the bile that flows through it.
Through Cholangio.Org, we unlock the biology, cause and prevention of cholangiocarcinoma.
Through Cholangiocarcinoma Foundation Australia, we turn that understanding into an end-to-end patient survival and prevention system.
Me In One Sentence:
My brother and I faced the same terminal cancer. He died without understanding how to respond. I found that understanding, and now turn it into survival and prevention for others.